This multi-peptide complex combines the angiogenic fragment BPC-157 with the actin-sequestering protein TB-500 to investigate bidirectional tissue remodeling synergy. It serves as a specialized reagent for exploring the concurrent activation of the VEGFR2 pathway and G-actin buffer systems in complex wound-healing assays. For research use only.
The BPC-157 + TB-500 Blend is a lyophilized synergistic complex designed for researchers studying multifaceted regenerative responses. By combining these two distinct molecular messengers, scientists can evaluate how the cytoprotective properties of the gastric pentadecapeptide interact with the actin-binding motility of Thymosin Beta-4. This reagent is valued for its ability to influence various growth factors and the nitric oxide (NO) system without altering the systemic coagulation cascade. This blend allows for the study of accelerated cellular migration alongside stabilized vascular formation, providing a more comprehensive model for connective tissue architectural restoration. It is intended strictly for laboratory research; it is not for human or veterinary administration.
